Your browser doesn't support javascript.
loading
Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.
Hsu, Ray C J; Barclay, Matthew; Loughran, Molly A; Lyratzopoulos, Georgios; Gnanapragasam, Vincent J; Armitage, James N.
Afiliação
  • Hsu RCJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.
  • Barclay M; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Loughran MA; The Healthcare Improvement Studies (THIS) Institute, University of Cambridge, Cambridge, UK.
  • Lyratzopoulos G; Transforming Cancer Services Team, National Health Service, London, UK.
  • Gnanapragasam VJ; National Cancer Registration and Analysis Service, Public Health England, London, UK.
  • Armitage JN; The Healthcare Improvement Studies (THIS) Institute, University of Cambridge, Cambridge, UK.
BJU Int ; 122(4): 599-609, 2018 10.
Article em En | MEDLINE | ID: mdl-29603575
ABSTRACT

OBJECTIVE:

To describe the temporal trends in nephrectomy practice and outcomes for English patients with renal cell carcinoma (RCC). PATIENTS AND

METHODS:

Adult RCC nephrectomy patients treated between 2000 and 2010 were identified in the National Cancer Data Repository and Hospital Episode Statistics, and followed-up until date of death or 31 December 2015 (n = 30 763). We estimated the annual frequency for each nephrectomy type, the hospital and surgeon numbers and their case volumes. We analysed short-term surgical outcomes, as well as 1- and 5-year relative survivals.

RESULTS:

Annual RCC nephrectomy number increased by 66% during the study period. Hospital number decreased by 24%, whilst the median annual hospital volume increased from 10 to 23 (P < 0.01). Surgeon number increased by 27% (P < 0.01), doubling the median consultant number per hospital. The proportion of minimally invasive surgery (MIS) nephrectomies rose from 1% to 46%, whilst the proportion of nephron-sparing surgeries (NSS) increased from 5% to 16%, with 29% of all T1 disease treated with partial nephrectomy in 2010 (P < 0.01). The 30-day mortality rate halved from 2.4% to 1.1% and 90-day mortality decreased from 4.9% to 2.6% (P < 0.01). The 1-year relative survival rate increased from 86.9% to 93.4%, whilst the 5-year relative survival rate rose from 68.2% to 81.2% (P < 0.01). Improvements were most notable in patients aged ≥65 years and those with T3 and T4 disease.

CONCLUSIONS:

Surgical RCC management has changed considerably with nephrectomy centralisation and increased NSS and MIS. In parallel, we observed significant improvements in short- and long-term survival particularly for elderly patients and those with locally advanced disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Tratamentos com Preservação do Órgão / Neoplasias Renais / Nefrectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Tratamentos com Preservação do Órgão / Neoplasias Renais / Nefrectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article